JWBK208-24 December 8, 2007 15:53 Char Count= 0
Cytopathology 363
r
Poorly diff. large cell (carcinoma vs. lymphoma vs. melanoma) panel: CAM5.2, MNF116, EMA, LCA,
S100, HMB45, T-cell markers, B-cell markers, CD30
r
Poorly diff. small cell (SmCC vs. SCC vs. lymphoid vs. neuro/nephroblastoma vs. sarcoma) panel: CK,
desmin, LCA, T-cell markers, B-cell markers, Tdt, CD10, CD99, CD56, NSE, S100
r
Spindle cell (sarcoma vs. carcinoma vs. mesothelioma) panel: CK, vimentin, desmin, EMA, S100,
SMA ± myogenin/MyoD1, CD34, CD31, HMB45, c-kit
r
CK is occ. +ve in: synovial sarcoma, epithelioid sarcoma, myeloma, ALCL, leiomyosarcoma, epithe-
lioid angiosarcoma, RMS, chondrosarcoma, melanoma
r
S100 is occ. +ve in: RCC, breast carcinoma, mesothelioma. Only 50% of MPNST are S100 +ve
Site Selective Antibodies
r
PSA, TTF-1, surfactant, thyroglobulin, GCDFP15, uroplakin III
r
CK7 and CK20: if both are negative consider gastric, renal, prostate, HCC
r
ER/PgR: Strong: breast (but a weak or −ve reaction could also occur with breast CA)
Weak: sweat gland, endometrium, cervix, ovary
Negative: colorectal, lung, HCC
Lymph Nodes
See also ‘HIV and Opportunistic Disease’, below.
Some General Pointers
r
With cohesive cellular clumps on low power, consider: granulomas, histiocytic lesions, carcinomas
r
Clumps of histiocytes: check to see if epithelioid else it could be Kikuchi’s (look for apoptotic debris)
r
Large horrible cells: consider ALCL, HL and metastatic malignancy
r
Neck LN: before diagnosing SCC consider squamous metaplasia in a branchial cyst or in metastatic
PTC
Epithelioid Granulomas
r
Epithelioid M with admixed lymphocytes
r
The typical epithelioid M nucleus is slipper-shaped, vesicular, pale-staining ± nucleoli
Hodgkin Lymphoma (HL)
r
The background may be relatively hypocellular due to sclerosis
r
Features favouring H/RS cells over mimics (e.g. immunoblasts/carcinoma) are:
the atypical cells are few and scattered
mitoses are rare
nucleoli are large and red on Pap (pale blue on MGG)
paler, less basophilic cytoplasm
reticular chromatin (→ paler nucleoplasm)
r
Need to see classic RS cells to make a 1
st
diagnosis but mononuclear Hodgkin cells suffice for recurrence
Features Favouring Lymphoma over Reactive Lymph Node
r
Monomorphic population (or dimorphic in FCL with comma-shaped Cc), but can be mixture in TCL/HL
r
Lack of: ‘germinal centre structures’, tingible body M and admixed plasma cells (germinal centre
structures are loose aggregates of a mixture of cells of the types expected in a normal germinal centre)
r
Predominance of large cells ±↑mitoses and apoptotic debris (tingible body M may be seen, e.g. in
Burkitt’s)
r
Although some mixed populations may be present, these are not in ‘logical proportions’ – i.e. those
expected in a benign lymph node including any reactive pattern
HIV and Opportunistic Disease
Indications for FNA of LN in HIV Lymphadenopathy
r
LN size >2 cm in any peripheral site or
r
Tenderness or
r
Recent ↑size or
r
Deep-seated (mediastinal, retroperitoneal/peri-pancreatic, etc.)